Document de presse
2020.09.10
Epidemiological theory teaches us that a microbial agent introduced into a population stops circulating when the proportion of the population that is immune to...
Document de presse
2021.01.19
Scientists from the Institut Pasteur-TheraVectys Joint Laboratory recently published in Cell Host & Microbe1 the results of tests, in two preclinical...
Document de presse
2020.08.12
Since the late 1990s, immunotherapy has been the frontline treatment against lymphomas where synthetic antibodies are used to stop the proliferation of...
Document de presse
2020.07.15
Which patients will develop a severe form of Covid-19? This is a key question that needs to be answered to improve the individual management and prognosis of...
News
2020.07.09
The African trypanosome Trypanosoma brucei gambiense is a parasite responsible for chronic Human African Trypanosomiasis, more commonly known as sleeping...
News
2020.07.06
Infections in humans caused by the hepatitis B virus (HBV) represent a major public health problem. Despite the availability of effective protective vaccines,...
News
2020.07.03
Researchers evaluate how the new coronavirus rewires human proteins for its own replication, and identify several antiviral drugs ready for clinical trials.
To...
News
2020.06.10
An international study has demonstrated that the microbiota and the intestinal cell death triggered by chemotherapy stimulate the efficacy of the immune...
News
2020.06.04
Using state-of-the-art sequencing and bioinformatics techniques, scientists from the Institut Pasteur, working with fellow scientists from Israel and China,...
News
2020.06.02
Klebsiella bacteria are responsible for some of the most antibiotic-resistant infections. A major study on intestinal colonization by Klebsiella has shed light...